From NCPDP claim adjudication and PBM rejects to DIR fee reconciliation, 340B, and specialty prior authorizations — our pharmacy RCM team protects margin on every script.
98.2%
Clean Claim Rate for Pharmacy
<24 hrs
Specialty PA Turnaround
$19K/mo
Avg DIR Recovered
3%
Script Abandonment
WHY PHARMACY BILLING IS COMPLEX
Pharmacy margin is won and lost at the point of adjudication. These are the issues we resolve for retail, specialty, compounding, and LTC pharmacies.
DUR rejects, refill-too-soon, plan limitations, and NDC-not-covered rejections are resolved in real time so scripts aren't abandoned at the counter and revenue isn't lost to walk-aways.
Direct and Indirect Remuneration fees claw back margin weeks after dispensing. We reconcile DIR against every claim, flag underpayments, and quantify true net reimbursement per script.
High-cost specialty medications require clinical PAs, step therapy, and benefit investigations. Our team manages the full PA lifecycle to prevent $0-pay dispenses and inventory write-offs.
Covered-entity eligibility, contract pharmacy split-billing, and duplicate-discount avoidance demand precise claim tagging. We keep 340B capture compliant and audit-ready.
Compound claim segments, DAW codes, days-supply calculations, and quantity dispensed math are frequent rejection triggers. We bill them correctly the first time.
Manufacturer copay cards, foundation assistance, and primary/secondary COB sequencing are coordinated so patients can afford therapy and the pharmacy is made whole.
Pharmacy reimbursement is a real-time, high-volume, low-margin business — and a single mis-adjudicated claim or unreconciled DIR fee can erase the profit on dozens of scripts. Our pharmacy RCM specialists understand NCPDP claim formats, PBM contract logic, and the downstream fees that determine your true net.
When you partner with Aethera, you get a pharmacy-dedicated team that works your rejection queue, reconciles every remittance against expected reimbursement and DIR, manages specialty PAs end to end, and gives you script-level net-margin visibility — driving a 98.2% clean claim rate.
NCPDP D.0 claim submission and real-time adjudication support
PBM reject resolution (DUR, refill-too-soon, plan limits, NDC coverage)
DIR fee reconciliation and net-reimbursement reporting
Specialty pharmacy prior authorization and benefits investigation
340B split-billing, eligibility tracking, and duplicate-discount avoidance
Compounding claim segments and DAW code management
Coordination of benefits (primary/secondary/tertiary)
Manufacturer copay card and foundation assistance enrollment
Long-term care (LTC) cycle fill and per-diem billing
Medicare Part B vs. Part D determination for applicable drugs
Days-supply and quantity-dispensed validation
Audit response and PBM recoupment defense
BILLING REFERENCE
A sample of the pharmacy claim elements and program codes our team handles daily \u2014 each with payer- and PBM-specific rules.
| Code / Field | Description |
|---|---|
| NDC (11-digit) | National Drug Code identifying product, strength, and package |
| DAW 0-9 | Dispense As Written codes for brand/generic substitution |
| NCPDP D.0 | Telecommunication claim standard for pharmacy adjudication |
| J-codes (Part B) | HCPCS for provider-administered drugs billed medically |
| 340B Modifier | Claim identifiers for 340B-acquired drugs |
| Compound Segment | Multi-ingredient compound claim reporting |
| Days Supply | Calculated dispensing duration for the claim |
| PA / Override | Prior authorization and rejection override codes |
This specialty pharmacy was losing roughly $28,000/month to abandoned scripts from unresolved PA rejects and had never reconciled DIR fees against expected reimbursement. Net margin was invisible.
Clean Claim Rate
89%
98.2%
Abandoned Scripts
11%
3%
DIR Recovered
$0
$19K/mo
PA Turnaround
4 days
<24 hrs
FAQ
Common questions from pharmacy owners considering outsourcing their revenue cycle.
Yes. We handle all dispensing models — retail point-of-sale adjudication, specialty PA-heavy workflows, compounding claim segments, and LTC cycle-fill/per-diem billing — each with its own rules and reimbursement logic.
Absolutely. We reconcile every remittance against expected reimbursement and applied DIR fees, flag underpayments and clawbacks, and report net margin at the script level so you know your real profitability.
Our team manages the full PA lifecycle — benefits investigation, clinical documentation, step-therapy attestations, and appeals — so high-cost specialty scripts don't end in $0-pay dispenses or inventory write-offs.
Yes. We manage split-billing, covered-entity eligibility tracking, and duplicate-discount avoidance so your 340B capture stays compliant and audit-ready.
Most pharmacies are fully transitioned within 3–5 weeks, including switch/PBM credential setup, claim-feed integration, and parallel processing so there's no gap in adjudication.
Start with a free pharmacy billing assessment. We'll audit your reject patterns and DIR exposure and show you exactly where margin is leaking.
Get Free Pharmacy Assessment